These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10353206)

  • 21. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
    Mitchell TG; Perfect JR
    Clin Microbiol Rev; 1995 Oct; 8(4):515-48. PubMed ID: 8665468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in innate host immune responses to cryptococcosis.
    Garelnabi M; May RC
    Mem Inst Oswaldo Cruz; 2018; 113(7):e180060. PubMed ID: 29668826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during
    Neal LM; Qiu Y; Chung J; Xing E; Cho W; Malachowski AN; Sandy-Sloat AR; Osterholzer JJ; Maillard I; Olszewski MA
    J Immunol; 2017 Jul; 199(2):643-655. PubMed ID: 28615417
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection.
    Lortholary O; Improvisi L; Rayhane N; Gray F; Fitting C; Cavaillon JM; Dromer F
    Infect Immun; 1999 Dec; 67(12):6314-20. PubMed ID: 10569743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.
    Levitz SM
    Rev Infect Dis; 1991; 13(6):1163-9. PubMed ID: 1775849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcus neoformans seropositivity and some haematological parameters in HIV seropositive subjects.
    Chukwuanukwu RC; Uchenna N; Mbagwu SI; Chukwuanukwu TO; Charles O
    J Infect Public Health; 2020 Jul; 13(7):1042-1046. PubMed ID: 31831399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.
    Saha DC; Xess I; Zeng WY; Goldman DL
    Med Mycol; 2008 Aug; 46(5):457-63. PubMed ID: 18608912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection.
    Vecchiarelli A; Dottorini M; Pietrella D; Monari C; Retini C; Todisco T; Bistoni F
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):130-7. PubMed ID: 8049074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
    BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptococcosis in HIV infection of man: an epidemiological and immunological indicator?
    Arastéh K; Staib F; Grosse G; Futh U; L'Age M
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):153-63. PubMed ID: 8837378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
    Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
    Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dectin-1 is not required for the host defense to Cryptococcus neoformans.
    Nakamura K; Kinjo T; Saijo S; Miyazato A; Adachi Y; Ohno N; Fujita J; Kaku M; Iwakura Y; Kawakami K
    Microbiol Immunol; 2007; 51(11):1115-9. PubMed ID: 18037789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.
    Wozniak KL; Vyas JM; Levitz SM
    Infect Immun; 2006 Jul; 74(7):3817-24. PubMed ID: 16790753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heat shock protein (Hsp) 70 of Cryptococcus neoformans is associated with the fungal cell surface and influences the interaction between yeast and host cells.
    Silveira CP; Piffer AC; Kmetzsch L; Fonseca FL; Soares DA; Staats CC; Rodrigues ML; Schrank A; Vainstein MH
    Fungal Genet Biol; 2013 Nov; 60():53-63. PubMed ID: 23954835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 36. Host immunity to Cryptococcus neoformans.
    Rohatgi S; Pirofski LA
    Future Microbiol; 2015; 10(4):565-81. PubMed ID: 25865194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.
    Huffnagle GB; Toews GB; Burdick MD; Boyd MB; McAllister KS; McDonald RA; Kunkel SL; Strieter RM
    J Immunol; 1996 Nov; 157(10):4529-36. PubMed ID: 8906831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recognition of Cryptococcus neoformans by Pattern Recognition Receptors and its Role in Host Defense to This Infection].
    Sato K; Kawakami K
    Med Mycol J; 2017; 58(3):J83-J90. PubMed ID: 28855484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
    Pietrella D; Lupo P; Perito S; Mosci P; Bistoni F; Vecchiarelli A
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):63-70. PubMed ID: 14734188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.
    Meyohas MC; Roux P; Bollens D; Chouaid C; Rozenbaum W; Meynard JL; Poirot JL; Frottier J; Mayaud C
    Clin Infect Dis; 1995 Sep; 21(3):628-33. PubMed ID: 8527555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.